Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome

British Journal of Haematology

Volumn 153, Issue 1, 2011, Pages 118-120

  Ghoti, Hussam ^a   Fibach, Eitan ^b   Westerman, Mark ^c   Gordana, Olbina ^c   Ganz, Tomas ^d   Rachmilewitz, Eliezer A ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Intrinsic LifeSciences LLC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chelator; Ineffective erythropoiesis; Iron overload; Myelodysplastic syndrome; Oxidative stress

Indexed keywords

DEFERASIROX; FERRITIN; HEPCIDIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; ERYTHROPOIESIS; FEMALE; HUMAN; IRON CHELATION; IRON OVERLOAD; MALE; MYELODYSPLASTIC SYNDROME; OXIDATIVE STRESS; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; TREATMENT DURATION;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BENZOIC ACIDS; BLOOD TRANSFUSION; ERYTHROPOIESIS; FEMALE; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OXIDATIVE STRESS; TRANSFERRIN; TRIAZOLES;

EID: 79952607559     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08587.x     Document Type: Article

References (14)

1. Choi, S.O., Cho, Y.S., Kim, H.L. & Park, J.W. (2007) ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochemical and biophysical research communications, 356, 312-317.
2. Fibach, E. & Rachmilewitz, E. (2008) The role of oxidative stress in hemolytic anemia. Current Molecular Medicine, 8, 609-619.
3. Ganz, T. (2008) Iron homeostasis: fitting the puzzle pieces together. Cell Metabolism, 7, 288-290.
4. Ganz, T., Olbina, G., Girelli, D., Nemeth, E. & Westerman, M. (2008) Immunoassay for human serum hepcidin. Blood, 112, 4292-4297.
5. Ghoti, H., Amer, J., Winder, A., Rachmilewitz, E. & Fibach, E. (2007) Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. European journal of haematology, 79, 463-467.
6. Ghoti, H., Fibach, E., Merkel, D., Perez-Avraham, G., Grisariu, S. & Rachmilewitz, E.A. (2010) Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes. Haematologica, 95, 1433-1434.
7. Lee, P.L. & Beutler, E. (2009) Regulation of hepcidin and iron-overload disease. Annual Review of Pathology, 4, 489-515.
8. Miura, K., Taura, K., Kodama, Y., Schnabl, B. & Brenner, D.A. (2008) Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology, 48, 1420-1429.
9. Murphy, P.T., Mitra, S., Gleeson, M., Desmond, R. & Swinkels, D.W. (2009) Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome. British Journal of Haematology, 144, 451-452.
10. Peyssonnaux, C., Zinkernagel, A.S., Schuepbach, R.A., Rankin, E., Vaulont, S., Haase, V.H., Nizet, V. & Johnson, R.S. (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). The Journal of Clinical Investigation, 117, 1926-1932.
11. Prus, E. & Fibach, E. (2011) Uptake of non-transferrin iron by erythroid cells. Anemia, 2011, Article ID 945289, doi:.
12. Ramirez, J.M., Schaad, O., Durual, S., Cossali, D., Docquier, M., Beris, P., Descombes, P. & Matthes, T. (2009) Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. British Journal of Haematology, 144, 251-262.
13. Tanno, T., Bhanu, N.V., Oneal, P.A., Goh, S.H., Staker, P., Lee, Y.T., Moroney, J.W., Reed, C.H., Luban, N.L., Wang, R.H., Eling, T.E., Childs, R., Ganz, T., Leitman, S.F., Fucharoen, S. & Miller, J.L. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Medicine, 13, 1096-1101.
14. Winder, A., Lefkowitz, R., Ghoti, H., Leiba, M., Ganz, T., Nemeth, E. & Rachmilewitz, E.A. (2008) Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis. British Journal of Haematology, 142, 669-671.